Hangzhou Alltest Biotech Co., Ltd. (688606.SS)
CNY 63.09
(-3.68%)
CNY 63.09
(-3.68%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 374.03 Million CNY | -81.87% |
| 2022 | 2.03 Billion CNY | 96.5% |
| 2021 | 1.03 Billion CNY | 10.65% |
| 2020 | 933.99 Million CNY | 521.35% |
| 2019 | 150.31 Million CNY | 29.76% |
| 2018 | 115.84 Million CNY | 41.4% |
| 2017 | 81.92 Million CNY | 82.76% |
| 2016 | 44.82 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 126.48 Million CNY | 7.29% |
| 2024 Q1 | 100.21 Million CNY | 0.36% |
| 2024 Q2 | 117.89 Million CNY | 17.63% |
| 2023 Q3 | 87.53 Million CNY | 55.47% |
| 2023 FY | 368.13 Million CNY | -81.87% |
| 2023 Q4 | 99.86 Million CNY | 14.09% |
| 2023 Q2 | 56.3 Million CNY | -54.76% |
| 2023 Q1 | 124.44 Million CNY | 21.23% |
| 2022 FY | 2.03 Billion CNY | 96.5% |
| 2022 Q3 | 134.49 Million CNY | -63.58% |
| 2022 Q2 | 369.29 Million CNY | -74.07% |
| 2022 Q1 | 1.42 Billion CNY | 293.58% |
| 2022 Q4 | 102.64 Million CNY | -23.68% |
| 2021 Q1 | 205.38 Million CNY | -50.8% |
| 2021 Q4 | 361.91 Million CNY | 66.16% |
| 2021 Q3 | 217.8 Million CNY | -12.31% |
| 2021 Q2 | 248.38 Million CNY | 20.93% |
| 2021 FY | 1.03 Billion CNY | 10.65% |
| 2020 Q4 | 417.48 Million CNY | 335.0% |
| 2020 Q3 | 95.97 Million CNY | -74.14% |
| 2020 Q2 | 371.13 Million CNY | 651.29% |
| 2020 Q1 | 49.39 Million CNY | 24.64% |
| 2020 FY | 933.99 Million CNY | 521.35% |
| 2019 Q4 | 39.63 Million CNY | 0.0% |
| 2019 FY | 150.31 Million CNY | 29.76% |
| 2018 FY | 115.84 Million CNY | 41.4% |
| 2017 FY | 81.92 Million CNY | 82.76% |
| 2016 FY | 44.82 Million CNY | 0.0% |